3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
67
Carcinoma, Non-Small-Cell Lung
45
Lung Neoplasms
42
Lymphoma
36
Prostatic Neoplasms
35
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Ovarian Neoplasms
27
Uterine Cervical Neoplasms
23
Central Nervous System Neoplasms
22
Neoplasm Metastasis
21
Fallopian Tube Neoplasms
21
Colorectal Neoplasms
21
Leukemia
20
Neuroblastoma
17
Head and Neck Neoplasms
17
Rectal Neoplasms
16
Brain Neoplasms
16
Adenocarcinoma of Lung
16
Sarcoma
15
Squamous Cell Carcinoma of Head and Neck
14
Glioblastoma
14
Colonic Neoplasms
14
Burkitt Lymphoma
14
Leukemia, Myeloid, Acute
13
HIV Infections
13
Urinary Bladder Neoplasms
12
Lymphoma, Large B-Cell, Diffuse
12
Multiple Myeloma
11
Hodgkin Disease
11
Astrocytoma
11
Interventions
osimertinib
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Has results
×
Non Small Cell Lung Cancer Metastatic
×
Clear all
NCT03133546
2026-02-06
BOOSTER
ETOP IBCSG Partners Foundation
Phase 2
Completed
155 enrolled
23 charts